Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 1, 2007, Pages

  Spratt, D I ^a,b   Frohnauer, M ^c   Cyr Alves, H ^a   Kramer, R S ^b   Lucas, F L ^b   Morton, J R ^b   Cox, D F ^b   Becker, K ^a   Devlin, J T ^c  

^a Maine Medical Center Research Institute   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c Maine Center for Endocrinology   (United States)

Author keywords

Estrogen; Hemodynamics; Protein flux; Testosterone; Triiodothyronine

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBON 13; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ESTROGEN; GROWTH HORMONE; IRON; LEUCINE; LIOTHYRONINE; NITRATE; NITROGEN; NITROPRUSSIDE SODIUM; PLACEBO; PROTEIN; SOMATOMEDIN C; TESTOSTERONE;

ACUTE DISEASE; AGED; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART INDEX; HEART SURGERY; HUMAN; IRON BINDING CAPACITY; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NITROGEN URINE LEVEL; NONTHYROIDAL ILLNESS SYNDROME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEGRADATION; PROTEIN METABOLISM; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; STATISTICAL SIGNIFICANCE; SWAN GANZ CATHETER;

ARRHYTHMIA; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EUTHYROID SICK SYNDROMES; FEMALE; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; IRON; MALE; MIDDLE AGED; PLACEBOS; POSTOPERATIVE PERIOD; THYROTROPIN; TRIIODOTHYRONINE;

EID: 34547121958     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00687.2006     Document Type: Article

References (37)

1. Association of Agricultural Chemists. Official Methods of Analysis. Washington, DC: Association of Agricultural Chemists, 1963.
2. 3on the incidence of atrial fibrillation in patients undergoing coronary artery bypass surgery (Online). http://www. clinicaltrials.gov/ct/show/NCT00289367?order=1 [16 Nov 2006].
3. Anonymous. Study of Triostat in infants during heart surgery [Online]. http://www.clinicaltrials.gov/ct/show/NCT00027417 [16 Nov 2006].
4. 3 Study Group. JAMA 275: 687-692, 1996.
5. Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356: 529-534, 2000.
6. Canbaz S, Ege T, Sunar H, Cikirikcioglu M, Acipayam M, Duran E. The effects of cardiopulmonary bypass on androgen hormones in coronary artery bypass surgery. J Int Med Res 30: 9-14, 2002.
7. Cerillo AG, Storti S, Mariani M, Kallushi E, Bevilacqua S, Parri MS, Clerico A, Glauber M. The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study. Clin Chem Lab Med 43: 289-293, 2005.
8. Chopra IJ. Clinical review 86: euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 82: 329-334, 1997.
9. Darveau M, Denault AY, Blais N, Notebaert E. Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 8: 356-362, 2004.
10. De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 22: 57-86, 2006.
11. DeGroot LJ. "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge. J Endocrinol Invest 26: 1163-1170, 2003.
12. Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 300: 579-584, 1979.
13. Guden M, Akpinar B, Saggbas E, Sanisoglu I, Cakali E, Bayindir O. Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovasc Thorac Ann 10: 219-222, 2002.
14. Holland FW 2nd, Brown PS Jr, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome." Ann Thorac Surg 52: 46-50, 1991.
15. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid 7: 139-145, 1997.
16. Klein IL. The cardiovascular system in hypothyroidism. In: The Thyroid: A Fundamental and Clinical Text, edited by E Lewis, M Braverman, and RD Utiger. Baltimore, MD: Lippincott Williams & Wilkins, 2005, p. 774-780.
17. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333: 1522-1527, 1995.
18. Krassas GE. The male and female reproductive system in hypothyroidism. In: The Thyroid: A Fundamental and Clinical Text, edited by E Lewis, M Braverman, and RD Utiger. Baltimore, MD: Lippincott Williams & Wilkins, 2005, p. 824-829.
19. Langton JE, Brent GA. Nonthyroidal illness syndrome: evaluation of thyroid function in sick patients. Endocrinol Metab Clin North Am 31: 159-172, 2002.
20. Longcope C, Franz C, Morello C, Baker R, Johnston CC JR. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 8: 189-196, 1986.
21. Longcope C, Watson D, Williams KI. The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol. Steroids 24: 15-30, 1974.
22. Maggio M, Ceda GP, De Cicco G, Cattadori E, Visioli S, Ablondi F, Beghi C, Gherli T, Basaria S, Ceresini G, Valenti G, Ferrucci L. Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting. J Endocrinol Invest 28: 711-719, 2005.
23. Marqusee Ellen M, Susan J. The blood in hypothyroidism. In: The Thyroid: A Fundamental and Clinical Text, edited by Lewis E, Braverman M, and Utiger RD. Baltimore, MD: Lippincott Williams & Wilkins, 2005, p. 803-805.
24. 3C]leucine. Am J Physiol Endocrinol Metab 238: E473-E479, 1980.
25. 13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31: 1105-1112, 1982.
26. Mesotten D, Van den Berghe G. Changes within the GH/IGF-I/IGFBP axis in critical illness. Crit Care Clin 22: 17-28, 2006.
27. Novitzky D. Novel actions of thyroid hormone: the role of triiodothyronine in cardiac transplantation. Thyroid 6: 531-536, 1996.
28. Novitzky D, Cooper DK, Barton CI, Greer A, Chaffin J, Grim J, Zuhdi N. Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 98: 972-978, 1989.
29. Reinhardt W, Mocker V, Jockenhovel F, Olbricht T, Reinwein D, Mann K, Sadony V. Influence of coronary artery bypass surgery on thyroid hormone parameters. Horm Res 47: 1-8, 1997.
30. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 75: 1336-1341, 2003.
31. Spratt DI. Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated? Best Practice Res Clin Endocrinol Metab 15: 479-494, 2001.
32. Spratt DI, Bigos ST, Beitins I, Cox P, Longcope C, Orav J. Both hyper-and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins. J Clin Endocrinol Metab 75: 1562-1570, 1992.
33. Spratt DI, Cox PM, Morton JR, Nye L, Goodale K. Cardiac surgery as a prospective model for the study of endocrinology in critical illness. Annu Meeting Am Coll Chest Physicians, New Orleans, LA, 1994.
34. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CPH. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab 291: E631-E638, 2006.
35. Stathatos N, Wartofsky L. The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Invest 26: 1174-1179, 2003.
36. Vavouranakis I, Sanoudos G, Manios A, Kalogeropoulou K, Sitaras K, Kokkinos C. Triiodothyronine administration in coronary artery bypass surgery: effect on hemodynamics. J Cardiovasc Surg (Torino) 35: 383-389, 1994.
37. Wartofsky L, Burman KD, Ringel MD. Trading one "dangerous dogma" for another? Thyroid hormone treatment of the "euthyroid sick syndrome." J Clin Endocrinol Metab 84: 1759-1760, 1999.